A(a)LS: Ammonia-induced amyotrophic lateral sclerosis

Area of Science:

• Neuroscience
• Biochemistry
• Pathology

Background:

• Amyotrophic lateral sclerosis (ALS) is a complex motor neuron disease with unexplained pathology.
• Current research indicates a multigenic and multifactorial etiology for ALS.
• Existing knowledge gaps hinder effective therapeutic development for ALS.

Purpose of the Study:

• To propose a novel integrative framework explaining ALS pathogenesis.
• To identify ammonia neurotoxicity as a central mechanism in ALS.
• To explore the role of hepatic urea cycle and skeletal muscle metabolism in ammonia regulation.

Main Methods:

• Extensive literature review to synthesize existing data.
• Development of a theoretical model integrating biochemical and physiological pathways.
• Analysis of ammonia's neurotoxic mechanisms and interaction with calcium binding proteins.

Main Results:

• Chronic hyperammonia, resulting from impaired hepatic urea cycle and increased skeletal muscle ammoniagenesis, is implicated in ALS.
• Elevated ammonia damages motor neurons via impaired autophagy, ER stress, oxidative stress, and neuroinflammation.
• Loss of neuroprotective calcium binding proteins (calbindin, calreticulin, parvalbumin) correlates with clinical variability.

Conclusions:

• Ammonia neurotoxicity provides a unifying explanation for ALS pathogenesis.
• The proposed framework highlights the interplay between metabolic dysfunction and neurodegeneration.
• This model may be generalizable to other neurodegenerative disorders like Huntington's disease and Parkinsonism.